|
1.
|
|
3 p, 444.0 KB |
Prevention of veno-occlusive disease/sinusoidal obstruction syndrome : a never-ending story and no easy answer
/
Corbacioglu, Selim (University of Regensburg) ;
Grupp, S.A. (The Children's Hospital of Philadelphia) ;
Richardson, Paul G.. (Dana-Farber Cancer Institute (Estats Units d'Amèrica)) ;
Duarte, R. (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Pagliuca, A. (King's College Hospital and Anthony Nolan Research Institute) ;
Ruutu, T. (Helsinki University Hospital) ;
Mahadeo, K. (Duke University Children's Hospital) ;
Carreras, Enric (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras)
2023 -  10.1038/s41409-023-02007-2
Bone marrow transplantation, Vol. 58 Núm. 8 (august 2023) , p. 839-841
|
|
|
2.
|
|
7 p, 793.0 KB |
Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation : A retrospective analysis of the EBMT chronic malignancies working party
/
Scheid, C. (University of Cologne) ;
De Wreede, L. (DKMS. German Bone Marrow Donor Center) ;
Van Biezen, A. (Leiden University Medical Center) ;
Koenecke, C. (Hannover Medical School) ;
Göhring, G. (Hannover Medical School) ;
Volin, L. (HUCH Comprehensive Cancer Center) ;
Maertens, J. (University Hospitals Gasthuisberg (Leuven, Bélgica)) ;
Finke, J. (University of Freiburg) ;
Passweg, J. (University Hospital) ;
Beelen, D. (University Hospital) ;
Cornelissen, J. J. (University Medical Center Rotterdam) ;
Itälä-Remes, M. (Turku University Hospital (Finlàndia)) ;
Chevallier, P. (CHU Nantes) ;
Russell, N. (Nottingham University) ;
Petersen, E. (University Medical Centre) ;
Milpied, N. (Hôpital Haut-leveque) ;
Richard Espiga, C. (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ;
Peniket, A. (Churchill Hospital) ;
Sierra Llopart, Jordi (Institut d'Investigació Biomèdica Sant Pau) ;
Mufti, G. (GKT School of Medicine) ;
Crawley, C. (Addenbrookes Hospital (Cambridge, Regne Unit)) ;
Veelken, J.H. (Leiden University Hospital) ;
Ljungman, P. (Karolinska University Hospital and Karolinska Institutet (Suecia)) ;
Cahn, Jean-Yves (Hopital A. Michallon) ;
Alessandrino, E.P. (Fondazione IRCCS Policlinico San Matteo) ;
De Witte, T. (Radboud University-Nijmegen Medical Centre) ;
Robin, M. (Hopital St. Louis) ;
Kröger, N. (University Hospital Eppendorf) ;
Universitat Autònoma de Barcelona
The International Prognostic Scoring System has been revised (IPSS-R) to predict prognosis of patients with myelodysplastic syndromes at diagnosis. To validate the use of the IPSS-R assessed before transplant rather than at diagnosis we performed a retrospective analysis of the EBMT database. [...]
2017 - 10.1038/bmt.2017.171
Bone marrow transplantation, Vol. 52 Núm. 11 (january 2017) , p. 1519-1525
|
|
|
3.
|
|
10 p, 856.3 KB |
Analysis of data collected in the European Society for Blood and Marrow Transplantation (EBMT) Registry on a cohort of lymphoma patients receiving plerixafor
/
Sureda, Anna (Institut Català d'Oncologia) ;
Chabannon, Christian (Institut Paoli-Calmettes) ;
Masszi, Tamás (Semmelweis University) ;
Pohlreich, David (Charles University Hospital) ;
Scheid, Christof (University of Cologne) ;
Thieblemont, Catherine (Hôpital Saint-Louis) ;
Wahlin, Björn E. (Karolinska University Hospital and Karolinska Institutet (Suecia)) ;
Sakellari, Ioanna (George Papanicolaou General Hospital) ;
Russell, Nigel (Nottingham University Hospital) ;
Janikova, Andrea (University Hospital Brno (República Txeca)) ;
Dabrowska-Iwanicka, Anna (Maria Sklodowska-Curie Institute-Oncology Center) ;
Touzeau, Cyrille (CHU Nantes) ;
Esquirol, Albert (Institut d'Investigació Biomèdica Sant Pau) ;
Jantunen, Esa (University of Eastern Finland and Kuopio University Hospital) ;
van der Werf, Steffie (EBMT Data Office) ;
Bosman, Paul (EBMT Data Office) ;
Boumendil, Ariane (EBMT Statistical Unit) ;
Liu, Qianying (Sanofi Genzyme) ;
Celanovic, Marina (Sanofi Genzyme) ;
Montoto, Silvia (St Bartholomew's Hospital) ;
Dreger, Peter (University of Heidelberg) ;
Universitat Autònoma de Barcelona
Plerixafor + granulocyte-colony stimulating factor (G-CSF) is administered to patients with lymphoma who are poor mobilizers of hematopoietic stem cells (HSCs) in Europe. This international, multicenter, non-interventional registry study (NCT01362972) evaluated long-term follow-up of patients with lymphoma who received plerixafor for HSC mobilization versus other mobilization methods. [...]
2020 - 10.1038/s41409-019-0693-z
Bone marrow transplantation, Vol. 55 Núm. 3 (january 2020) , p. 613-622
|
|
|
4.
|
|
8 p, 930.0 KB |
Ruxolitinib in refractory acute and chronic graft-versus-host disease : a multicenter survey study
/
Escamilla Gómez, V. (Universidad de Sevilla) ;
García-Gutiérrez, Valentín (University Hospital Ramon y Cajal) ;
López Corral, Lucía (Complejo Asistencial Universitario de Salamanca-IBSAL) ;
Garcia Cadenas, Irene (Institut d'Investigació Biomèdica Sant Pau) ;
Pérez Martínez, Ariadna (Hospital Clínic Universitari (València)) ;
Márquez Malaver, F.J. (Universidad de Sevilla) ;
Caballero Velazquez, Teresa (Universidad de Sevilla) ;
González Sierra, P.A. (Hospital Universitario (Granada)) ;
Viguria Alegría, M.C. (Complejo Hospitalario de Navarra) ;
Parra Salinas, I.M. (Hospital Universitario Miguel Servet (Saragossa)) ;
Calderón Cabrera, C. (Universidad de Sevilla) ;
González Vicent, M. (Hospital Infantil Universitario Niño Jesús (Madrid)) ;
Rodríguez Torres, N. (Universidad de Sevilla) ;
Parody Porras, R. (Instituto Catalá de Oncología Hospitalet) ;
Ferrá, Christelle (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Orti, Guillermo (Hospital Universitari Vall d'Hebron) ;
Valcárcel Ferreiras, D. (Hospital Universitari Vall d'Hebron) ;
de la Camara, Rafael (Hospital Universitario de la Princesa (Madrid)) ;
Molés, P. (Hospital Universitari i Politècnic La Fe (València)) ;
Velázquez-Kennedy, K. (Hospital Universitari Ramon y Cajal) ;
João Mende, M. (Complejo Asistencial Universitario de Salamanca-IBSAL) ;
Caballero, Dolores (Complejo Asistencial Universitario de Salamanca-IBSAL) ;
Pérez, Estefanía (Complejo Asistencial Universitario de Salamanca-IBSAL) ;
Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ;
Saavedra Gerosa, Silvana Daniela (Institut d'Investigació Biomèdica Sant Pau) ;
Sierra, Jorge (Institut d'Investigació Biomèdica Sant Pau) ;
Poch, M. (Clinic Hospital Universitari de Valencia) ;
Zudaire Ripa, M.T. (Complejo Hospitalario de Navarra) ;
Díaz Pérez, M.A. (Hospital Infantil Universitario Niño Jesús (Madrid)) ;
Molina Angulo, B. (Hospital Infantil Universitario Niño Jesús (Madrid)) ;
Sánchez Ortega, I. (Instituto Catalá de Oncología Hospitalet) ;
Sanz Caballer, J. (Hospital Universitari i Politècnic La Fe (València)) ;
Montoro Gómez, J. (Hospital Universitari i Politècnic La Fe (València)) ;
Espigado Tocino, I. (Universidad de Sevilla) ;
Pérez-Simón, J.A. (Universidad de Sevilla) ;
Universitat Autònoma de Barcelona
Graft-versus-host disease is the main cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation. First-line treatment is based on the use of high doses of corticosteroids. [...]
2020 - 10.1038/s41409-019-0731-x
Bone marrow transplantation, Vol. 55 Núm. 3 (january 2020) , p. 641-648
|
|
|
5.
|
|
2 p, 458.6 KB |
Role of Hospital Exemption in Europe : position paper from the Spanish Advanced Therapy Network
/
Sanchez-Guijo, Fermin (Universidad de Salamanca) ;
Badimon, Lina (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Avendaño Sola, Cristina (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Bueren, Juan (Centro de Investigación Biomédica en Red de Enfermedades Raras) ;
Canals, Josep M. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Delgadillo Duarte, Joaquin (Banc de Sang i Teixits) ;
Delgado, Julio (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Eguizábal, Cristina (Instituto de Investigación Sanitaria Biocruces Bizkaia) ;
Fernández-Santos, María-Eugenia (Gregorio Marañón General University Hospital) ;
García-Olmo, Damián (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ;
González-Aseguinolaza, Gloria (Universidad de Navarra) ;
Juan, Manel (Hospital Clínic i Provincial de Barcelona) ;
Martín, Francisco (Universidad de Granada. Departamento de Bioquímica y Biología Molecular III e Inmunología) ;
Mata, Rosario (Coordination Unit of the Andalusian Network for the Design and Translation of Advanced Therapies) ;
Montserrat, Nuria (Institució Catalana de Recerca i Estudis Avançats) ;
Pérez-Martínez, Antonio (Universidad Autónoma de Madrid) ;
Pérez-Simón, José Antonio (Universidad de Sevilla. Department of Hematology) ;
Prosper, Felipe (Clínica Universidad de Navarra) ;
Urbano Ispizua, Álvaro (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Zapata, Agustín G. (Complutense University. Faculty of Biology. Dept of Cell Biology) ;
Sureda, Anna (Universitat de Barcelona. Departament d'hematologia) ;
Moraleda, José María (University of Murcia) ;
Universitat Autònoma de Barcelona
2023 - 10.1038/s41409-023-01962-0
Bone marrow transplantation, Vol. 58 (march 2023) , p. 727-728
|
|
|
6.
|
|
9 p, 612.9 KB |
Bariatric surgery increases the rate of major fracture : self-controlled case series study in Clinical Practice Research Datalink
/
Robinson, Danielle E. (University of Oxford) ;
Douglas, Ian (London School of Hygiene & Tropical) ;
Tan, Garry D. (The National Institute for Health Research (NIHR) Oxford Biomedical Research Centre) ;
Delmestri, Antonella (University of Oxford) ;
Judge, Andrew (University of Bristol) ;
Cooper, Cyrus (University of Oxford) ;
Javaid, M. Kassim (University of Southampton) ;
Strauss, Victoria Y. (University of Oxford) ;
Prieto-Alhambra, Daniel (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ;
Universitat Autònoma de Barcelona
Conflicting results exist about the relationship between bariatric surgery and fracture risk. Also, prediction of who is at increased risk of fracture after bariatric surgery is not currently available. [...]
2021 - 10.1002/jbmr.4405
Journal of Bone and Mineral Research, Vol. 36 (july 2021) , p. 2153-2161
|
|
|
7.
|
|
11 p, 548.2 KB |
Estimating the Incidence and Key Risk Factors of Cardiovascular Disease in Patients at High Risk of Imminent Fracture Using Routinely Collected Real-World Data From the
/
Pineda-Moncusí, Marta (University of Oxford) ;
El-Hussein, Leena (University of Oxford) ;
Delmestri, Antonella (University of Oxford) ;
Cooper, Cyrus (University of Southampton) ;
Moayyeri, Alireza (UCB Biopharma Sprl) ;
Libanati, Cesar (UCB Biopharma Sprl) ;
Toth, Emese (UCB Biopharma Sprl) ;
Prieto-Alhambra, Daniel (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ;
Khalid, Sara (University of Oxford) ;
Universitat Autònoma de Barcelona
The objective of this work was to estimate the incidence rate of cardiovascular disease (CVD) events (myocardial infarction, stroke, or CVD death) at 1 year among three cohorts of patients at high risk of fracture (osteoporosis, previous fracture, and anti-osteoporosis medication) and to identify the key risk factors of CVD events in these three cohorts. [...]
2022 - 10.1002/jbmr.4648
Journal of Bone and Mineral Research, Vol. 37 (september 2022) , p. 1986-1996
|
|
|
8.
|
|
10 p, 878.6 KB |
Osteosynthesis-associated infection of the lower limbs by multidrug-resistant and extensively drug-resistant Gram-negative bacteria : a multicentre cohort study
/
Giannitsioti, Efthymia (Fourth Department of Internal Medicine. University General Hospital Attikon. School of Medicine. National and Kapodistrian University of Athens) ;
Salles, Mauro José (Division of Infectious Diseases. Department of Internal Medicine. Escola Paulista de Medicina. Universidade Federal de São Paulo (UNIFESP)) ;
Mavrogenis, Andreas (First Department of Orthopaedics. University General Hospital Attikon. School of Medicine. National and Kapodistrian University of Athens) ;
Rodriguez-Pardo, Dolors (Hospital Universitari Vall d'Hebron) ;
Los-Arcos, Ibai (Hospital Universitari Vall d'Hebron) ;
Ribera, Alba (Hospital Universitari de Bellvitge) ;
Ariza, Javier (Hospital Universitari de Bellvitge) ;
del Toro López, María Dolores (Instituto de Biomedicina de Sevilla) ;
Nguyen, Sophie (Infectious Diseases Department. Gustave Dron Hospital) ;
Senneville, Eric (Infectious Diseases Department. Gustave Dron Hospital) ;
Bonnet, Eric (Department of Infectious Diseases. Clinique Pasteur) ;
Chan, Monica (Department of Infectious Diseases. Tan Tock Seng Hospital) ;
Pasticci, Maria Bruna (Infectious Diseases Unit. University of Perugia) ;
Petersdorf, Sabine (Institute for Medical Laboratory Diagnostics. Helios University Clinic Wuppertal) ;
Benito, Natividad (Institut d'Investigació Biomèdica Sant Pau) ;
O'Connell, Nuala (Department of Clinical Microbiology. University Hospital Limerick) ;
Blanco García, Antonio (Fundación Jiménez Díaz. Unidad de Infección Ósea y Articular. Departamento de Medicina de Emergencia) ;
Skaliczki, Gábor (Department of Orthopaedics. Semmelweis University) ;
Tattevin, Pierre (Infectious Diseases and Intensive Care Unit. Pontchaillou University Hospital) ;
Kocak Tufan, Zeliha (Department of Infectious Diseases and Clinical Microbiology. Faculty of Medicine. Yildirim Beyazit University. Ankara Atatürk Education and Research Hospital) ;
Pantazis, Nikolaos (Department of Hygiene Epidemiology and Medical Statistics. School of Medicine. National and Kapodistrian University of Athens) ;
Megaloikonomos, Panayotis D. (First Department of Orthopaedics. University General Hospital Attikon. School of Medicine. National and Kapodistrian University of Athens) ;
Papagelopoulos, Panayotis (First Department of Orthopaedics. University General Hospital Attikon. School of Medicine. National and Kapodistrian University of Athens) ;
Soriano, A (Hospital Clínic i Provincial de Barcelona) ;
Papadopoulos, Antonios (Fourth Department of Internal Medicine. University General Hospital Attikon. School of Medicine. National and Kapodistrian University of Athens) ;
Universitat Autònoma de Barcelona
Purpose: The purpose of this study was the clinical and therapeutic assessment of lower-limb osteosynthesis-associated infection (OAI) by multidrug-resistant (MDR) and extensively drug-resistant (XDR) Gram-negative bacteria (GNB), which have been poorly studied to date. [...]
2022 - 10.5194/jbji-7-279-2022
Journal of Bone and Joint Infection, Vol. 7 Núm. 6 (December 2022) , p. 279-288
|
|
|
9.
|
|
8 p, 1.8 MB |
Benchmarking of survival outcomes following Haematopoietic Stem Cell Transplantation (HSCT) : an update of the ongoing project of the European Society for Blood and Marrow Transplantation (EBMT) and Joint Accreditation Committee of ISCT and EBMT (JACIE)
/
Saccardi, Riccardo (Careggi University Hospital (Florència, Itàlia)) ;
Putter, Hein (Leiden University Medical Center) ;
Eikema, Dirk-Jan (EBMT Statistical Unit Leiden) ;
Busto, María Paula (EBMT Registry) ;
McGrath, Eoin (ICCBBA (Barcelona, Espanya)) ;
Middelkoop, Bas (European Society for Blood and Marrow Transplantation-EBMT Registry) ;
Adams, Gillian (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ;
Atlija, Marina (European Society for Blood and Marrow Transplantation-EBMT Registry) ;
Ayuk, Francis (University Medical Center Hamburg) ;
Baldomero, Helen (University Hospital Basel (Basilea, Suïssa)) ;
Beguin, Yves (CHU of Liège and University of Liège) ;
de la Camara, Rafael (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ;
Cedillo Cedillo, Angel (Grupo Español de Trasplantes Hematopoyéticos y Terapia Celular) ;
Balari, Anna María Sureda (Hospital Universitari de Bellvitge) ;
Chabannon, Christian (Institut Paoli-Calmettes Comprehensive Cancer Centre) ;
Corbacioglu, Selim (University Children's Hospital Regensburg) ;
Dolstra, Harry (Radboud University Medical Center) ;
Duarte, Rafael (Universidad Autónoma de Madrid) ;
Duléry, Rémy (Sorbonne Université) ;
Greco, Raffaella (Autoimmune Diseases Working Party (Barcelona, Espanya)) ;
Gusi, Andreu (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ;
Hamad, Nada (University of Notre Dame Australia) ;
Kenyon, Michelle (King's College Hospital NHS Foundation Trust) ;
Kroeger, Nicolaus (University Medical Center Hamburg) ;
Labopin, Myriam (European Society for Blood and Marrow Transplantation-EBMT Paris Study Office) ;
Lee, Julia (British Society of Blood and Marrow Transplantation and Cellular Therapy (Regne Unit)) ;
Ljungman, Per (Karolinska University Hospital and Karolinska Institutet (Suècia)) ;
Manson, Lynn (Edinburgh & SE Scotland Clinical Transfusion Centre Patient Services (Regne Unit)) ;
Mensil, Florence (Agence de la Biomédecine) ;
Milpied, Noel (Centre Hospitalier Universitaire Bordeaux) ;
Mohty, Mohamad (Sorbonne University) ;
Oldani, Elena (Italian National BMT Registry) ;
Orchard, Kim (University Hospital Southampton NHS) ;
Passweg, Jakob (University Hospital Basel (Basilea, Suïssa)) ;
Pearce, Rachel (British Society of Blood and Marrow Transplantation and Cellular Therapy (Regne Unit)) ;
de Latour, Régis Peffault (BMT unit Paris Cité University) ;
Poirel, Hélène A. (Belgian Transplant Registry) ;
Rintala, Tuula (King's College Hospital NHS Foundation Trust) ;
Rizzo, J. Douglas (CIBMTR, Medical College of Wisconsin) ;
Ruggeri, Annalisa (IRCCS San Raffaele Scientific Institute (Milà, Itàlia)) ;
Sanchez-Martinez, Carla (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ;
Sanchez-Guijo, Fermin (CIC-University of Salamanca) ;
Sánchez-Ortega, Isabel (European Society for Blood and Marrow Transplantation-EBMT Executive Office (Barcelona, Espanya)) ;
Trnková, Marie (Czech registry Czech Republic) ;
Valcárcel, David (Vall d'Hebron Institut d'Oncologia) ;
Wilcox, Leonie (Australasian Bone Marrow Transplant Recipient Registry) ;
de Wreede, Liesbeth C. (Leiden University Medical Center) ;
Snowden, John A. (Sheffield Teaching Hospitals NHS Foundation Trust (Sheffield, Regne Unit)) ;
Universitat Autònoma de Barcelona
From 2016 EBMT and JACIE developed an international risk-adapted benchmarking program of haematopoietic stem cell transplant (HSCT) outcome to provide individual EBMT Centers with a means of quality-assuring the HSCT process and meeting FACT-JACIE accreditation requirements relating to 1-year survival outcomes. [...]
2023 - 10.1038/s41409-023-01924-6
Bone marrow transplantation, march 2023, p. 1-8
|
|
|
10.
|
|
visitant ::
identificació
alerta personal via correu electrònic o subscribiu-vos al 
canal RSS.
